您的位置: 首页 > 农业专利 > 详情页

ENGINEERED DENDRITIC CELLS AND USES FOR THE TREATMENT OF CANCER
专利权人:
UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION;INTREXON CORPORATION
发明人:
BRAUGHLER, J MARK,KUMAR, PRASANNA,STORKUS, WALTER J,OKADA, HIDEHO
申请号:
NZ58519008
公开号:
NZ585190A
申请日:
2008.10.08
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Disclosed is vector for conditionally expressing a protein having the function of interleukin-12 (lL-12), comprising a polynucleotide encoding a gene switch, said gene switch comprising: (l) at least one transcription factor sequence, wherein said at least one transcription factor sequence encodes a ligand dependent transcription factor, operably linked to a promoter, wherein said promoter is not a stress-inducible promoter, and (2) a polynucleotide encoding said protein having the function of IL-12 linked to a promoter which is activated by said ligand-dependent transcription factor, wherein said polynucleotide encoding said protein having the function of IL-12 encodes a polypeptide at least 85% identical to wild type human IL-12.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充